A comparative study of the recent most potent small-molecule PD-L1 inhibitors: what can we learn?

Liu, M; Zhang, Y; Guo, Y; Gao, J; Huang, WH; Dong, XW

Liu, M (corresponding author), Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Dept Neurol, Peoples Hosp, Hangzhou 310014, Peoples R China.

MEDICINAL CHEMISTRY RESEARCH, 2021; 30 (6): 1230

Abstract

Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have become a "game-changer" in the cancer treatment. However, none of the small molecul......

Full Text Link